<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02722928</url>
  </required_header>
  <id_info>
    <org_study_id>2015H0032</org_study_id>
    <nct_id>NCT02722928</nct_id>
  </id_info>
  <brief_title>Ventilation With High Oxygen Content and Postoperative Pneumocephalus</brief_title>
  <official_title>Impact of Intraoperative Ventilation With High Oxygen Content to Reduce the Incidence and Extent of Postoperative Pneumocephalus in Patients Undergoing Craniotomies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the incidence and volume of postoperative pneumocephalus
      in patients receiving ventilation with 100% oxygen during the last stage of surgery versus a
      conventional 1:1 oxygen/air gas mixture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Postoperative pneumocephalus is a common complication in patients undergoing
      craniotomies. Even though the treatment of postoperative pneumocephalus with the use of
      supplemental oxygen is well documented, yet not reports have shown its role for the
      prevention of this condition. We suggest the use of intraoperative ventilation with 100%
      oxygen as prophylaxis for the incidence and severity of postoperative pneumocephalus in
      patients undergoing intracranial surgery.

      Objectives: The aim of this study is to compare the incidence and volume of postoperative
      pneumocephalus in patients receiving ventilation with 100% oxygen during the last stage of
      surgery versus a conventional 1:1 oxygen/air gas mixture.

      Study Methods: A single-blinded, prospective study, randomizing 80 patients per group,
      expecting 80% power to detect a 20% decrease in pneumocephalus volume for the interventional
      group. Inclusion criteria: Patients &gt;18 years, scheduled to undergo elective craniotomy, and
      be willing to give written informed consent.

      Study Procedures: Once the tumor resection is completed and hemostasis started (beginning of
      stage 2), patients will be assigned to receive either 1:1 oxygen/air gas mixture (control
      group) or 100% oxygen (intervention group) until the end of the surgery. All patients will
      receive postoperative supplemental oxygen via nasal cannula. CT scan will be performed within
      1 to 6 postoperative hours as standard of care. A blinded radiologist will review all CT
      scans and assess the extent and frequency of postoperative pneumocephalus.

      Clinical Outcomes: Patients' demographic data, length of stage 2, period of time between the
      end of surgery and CT scan, and pneumocephalus volumetric measurements will be compared
      between groups. Baseline neurological status will be compared with clinical and imaging
      postoperative findings.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Variability of the pneumocephalus volume mean was higher than initially assumed
  </why_stopped>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">December 26, 2018</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Volume of Postoperative Pneumocephalus</measure>
    <time_frame>One to six hours after surgery</time_frame>
    <description>Compare the extent (cm3) of postoperative pneumocephalus in patients ventilated intraoperatively with 100% oxygen during hemostasis and wound closure versus 1:1 oxygen / air mixture</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of Postoperative Pneumocephalus</measure>
    <time_frame>One to six hours after surgery</time_frame>
    <description>Compare the occurrence rate of postoperative pneumocephalus (present or not present) in patients receiving intraoperative ventilation with 100% oxygen during hemostasis and wound closure versus 1:1 oxygen / air mixture</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pneumocephalus Volume and Anterior Fossa Surgery</measure>
    <time_frame>One to six hours after surgery</time_frame>
    <description>To compare the presence of postoperative pneumocephalus in patients who underwent anterior fossa surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumocephalus Volume and Posterior Fossa Surgery</measure>
    <time_frame>one to six hours after surgery</time_frame>
    <description>Pneumocephalus volume in patients who underwent posterior fossa surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Neurological Outcomes at POD 3 Compared to Preoperative Evaluation</measure>
    <time_frame>preoperative to postoperative day 3</time_frame>
    <description>Changes in Neurological Outcomes from baseline (preoperative evaluation) were documented based on differences (if any) found between both physical examinations: baseline (before surgery) and postoperative day (POD) 3 neurological exam. Results were reported as &quot;improvement&quot; (partial or total recovery of baseline neurological signs/symptoms), &quot;no changes&quot;, and &quot;deterioration&quot; (focal or global neurological deterioration) in comparison with baseline neurological examination</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Pneumocephalus</condition>
  <arm_group>
    <arm_group_label>Conventional 1:1 oxygen/air gas mixture</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>80 patients will receive ventilation during the surgery with a 1:1 oxygen / air gas mixture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pure oxygen ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive controlled ventilation with a conventional 1:1 oxygen / air gas mixture (60% oxygen concentration) during the approach and tumor removal phases. Once tumor resection is completed and hemostasis started, this group of patients will be switched to ventilation with 100% (pure) oxygen concentration</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Controlled Ventilation with 100% oxygen</intervention_name>
    <description>Patients in group B will be switched from conventional 1:1 oxygen / air ventilation to 100% oxygen controlled ventilation once tumor resection is completed and hemostasis started. They will inhale 100% oxygen until extubation</description>
    <arm_group_label>Pure oxygen ventilation</arm_group_label>
    <other_name>FiO2 100% after tumor resection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18 years of both sexes undergoing surgical procedures to treat hemispheric
             or posterior cranial fossa tumors and consenting to the study

        Exclusion Criteria:

          -  History of severe cardio-pulmonary disease.

          -  Bleeding disorders

          -  Previous neurosurgeries requiring cranial reconstruction

          -  Head trauma

          -  Decreased consciousness related to cerebral edema
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gurneet Sandhu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology - Clinical Research</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Beppu T, Ogasawara K, Ogawa A. Alleviation of intracranial air using carbon dioxide gas during intraventricular tumor resection. Clin Neurol Neurosurg. 2006 Oct;108(7):655-60. Epub 2006 Feb 14.</citation>
    <PMID>16483713</PMID>
  </reference>
  <reference>
    <citation>Schirmer CM, Heilman CB, Bhardwaj A. Pneumocephalus: case illustrations and review. Neurocrit Care. 2010 Aug;13(1):152-8. doi: 10.1007/s12028-010-9363-0. Review.</citation>
    <PMID>20405340</PMID>
  </reference>
  <reference>
    <citation>Gore PA, Maan H, Chang S, Pitt AM, Spetzler RF, Nakaji P. Normobaric oxygen therapy strategies in the treatment of postcraniotomy pneumocephalus. J Neurosurg. 2008 May;108(5):926-9. doi: 10.3171/JNS/2008/108/5/0926.</citation>
    <PMID>18447708</PMID>
  </reference>
  <reference>
    <citation>Aoki N, Sakai T. Computed tomography features immediately after replacement of haematoma with oxygen through percutaneous subdural tapping for the treatment of chronic subdural haematoma in adults. Acta Neurochir (Wien). 1993;120(1-2):44-6.</citation>
    <PMID>8434516</PMID>
  </reference>
  <reference>
    <citation>Branger AB, Lambertsen CJ, Eckmann DM. Cerebral gas embolism absorption during hyperbaric therapy: theory. J Appl Physiol (1985). 2001 Feb;90(2):593-600.</citation>
    <PMID>11160058</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>March 21, 2016</study_first_submitted>
  <study_first_submitted_qc>March 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2016</study_first_posted>
  <results_first_submitted>September 19, 2018</results_first_submitted>
  <results_first_submitted_qc>June 3, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 4, 2019</results_first_posted>
  <last_update_submitted>June 3, 2019</last_update_submitted>
  <last_update_submitted_qc>June 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Gurneet Sandhu</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Postoperative pneumocephalus</keyword>
  <keyword>Fraction of inspired oxygen</keyword>
  <keyword>Intracranial surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumocephalus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 8, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT02722928/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Conventional 1:1 Oxygen/Air Gas Mixture</title>
          <description>39 patients received ventilation during the surgery with a 1:1 oxygen / air gas mixture</description>
        </group>
        <group group_id="P2">
          <title>Pure Oxygen Ventilation</title>
          <description>31 patients received controlled ventilation with a conventional 1:1 oxygen / air gas mixture during the approach and tumor removal phases. Once tumor resection was completed and hemostasis started, this group of patients was switched to ventilation with pure oxygen (FiO2 = 100%) until extubation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Standard CT was not as required per prot</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Required Intraoperative MRI</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Conventional 1:1 Oxygen/Air Gas Mixture</title>
          <description>39 patients received ventilation during the surgery with a 1:1 oxygen / air gas mixture</description>
        </group>
        <group group_id="B2">
          <title>Pure Oxygen Ventilation</title>
          <description>31 patients received controlled ventilation with a conventional 1:1 oxygen / air gas mixture during the approach and tumor removal phases. Once tumor resection was completed and hemostasis started, this group of patients was switched to ventilation with pure oxygen (FiO2 = 100%) until extubation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="39"/>
            <count group_id="B2" value="31"/>
            <count group_id="B3" value="70"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.69" spread="14.21"/>
                    <measurement group_id="B2" value="50.81" spread="13.28"/>
                    <measurement group_id="B3" value="48.51" spread="13.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>Kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.35" spread="7.42"/>
                    <measurement group_id="B2" value="31.94" spread="6.64"/>
                    <measurement group_id="B3" value="31.61" spread="7.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>American Society of Anesthesiologists Physical Status (ASA PS)</title>
          <description>ASA PS classification describes the preoperative clinical status of the patient. ASA PS comprise 6 levels. The last 2 (ASA PS V and VI) are for moribund and brain death patients respectively and therefore, were not included in our patient setting. The following categories were included in our trial: ASA PS I: A normal healthy patient; ASA PS II: A patient with mild systemic disease; ASA PS III: A patient with severe systemic disease; ASA PS IV: A patient with severe systemic disease that is a constant threat to life</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>ASA PS I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ASA PS II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ASA PS III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ASA PS IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preoperative Diagnosis</title>
          <description>Supratentorial lesions are the ones located above the tentorium cerebelli (e.g. cerebral lesions) Infratentorial lesions are the ones located below the tentorium cerebelli (e.g. cerebellar lesions)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Supratentorial Lesion (above tentorium cerebelli)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Infratentorial Lesion (below tentorium cerebelli)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Volume of Postoperative Pneumocephalus</title>
        <description>Compare the extent (cm3) of postoperative pneumocephalus in patients ventilated intraoperatively with 100% oxygen during hemostasis and wound closure versus 1:1 oxygen / air mixture</description>
        <time_frame>One to six hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Conventional 1:1 Oxygen/Air Gas Mixture</title>
            <description>39 patients received ventilation during the surgery with a 1:1 oxygen / air gas mixture</description>
          </group>
          <group group_id="O2">
            <title>Pure Oxygen Ventilation</title>
            <description>31 patients received controlled ventilation with a conventional 1:1 oxygen / air gas mixture during the approach and tumor removal phases. Once tumor resection was completed and hemostasis started, this group of patients was switched to ventilation with pure oxygen (FiO2 = 100%) until extubation</description>
          </group>
        </group_list>
        <measure>
          <title>Volume of Postoperative Pneumocephalus</title>
          <description>Compare the extent (cm3) of postoperative pneumocephalus in patients ventilated intraoperatively with 100% oxygen during hemostasis and wound closure versus 1:1 oxygen / air mixture</description>
          <units>cm^3</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.65" lower_limit="3.61" upper_limit="23.20"/>
                    <measurement group_id="O2" value="7.06" lower_limit="2.70" upper_limit="20.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of Postoperative Pneumocephalus</title>
        <description>Compare the occurrence rate of postoperative pneumocephalus (present or not present) in patients receiving intraoperative ventilation with 100% oxygen during hemostasis and wound closure versus 1:1 oxygen / air mixture</description>
        <time_frame>One to six hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Conventional 1:1 Oxygen/Air Gas Mixture</title>
            <description>39 patients received ventilation during the surgery with a 1:1 oxygen / air gas mixture</description>
          </group>
          <group group_id="O2">
            <title>Pure Oxygen Ventilation</title>
            <description>31 patients received controlled ventilation with a conventional 1:1 oxygen / air gas mixture during the approach and tumor removal phases. Once tumor resection was completed and hemostasis started, this group of patients was switched to ventilation with pure oxygen (FiO2 = 100%) until extubation</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Postoperative Pneumocephalus</title>
          <description>Compare the occurrence rate of postoperative pneumocephalus (present or not present) in patients receiving intraoperative ventilation with 100% oxygen during hemostasis and wound closure versus 1:1 oxygen / air mixture</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pneumocephalus Volume and Anterior Fossa Surgery</title>
        <description>To compare the presence of postoperative pneumocephalus in patients who underwent anterior fossa surgery.</description>
        <time_frame>One to six hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Conventional 1:1 Oxygen/Air Gas Mixture</title>
            <description>Out of the 39 patients included in the Conventional 1:1 oxygen / air gas mixture ventilation group, 23 patients underwent conventional anterior fossa surgery. Pneumocephalus volume was compared between groups for this patient sub-setting</description>
          </group>
          <group group_id="O2">
            <title>Pure Oxygen Ventilation</title>
            <description>Out of the 31 patients in the pure oxygen ventilation after hemostasis group, 16 patients underwent conventional anterior fossa surgery. Pneumocephalus volume was compared between groups for this patient setting</description>
          </group>
        </group_list>
        <measure>
          <title>Pneumocephalus Volume and Anterior Fossa Surgery</title>
          <description>To compare the presence of postoperative pneumocephalus in patients who underwent anterior fossa surgery.</description>
          <units>cm^3</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.4" lower_limit="6.89" upper_limit="24.4"/>
                    <measurement group_id="O2" value="13.95" lower_limit="4.82" upper_limit="22.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pneumocephalus Volume and Posterior Fossa Surgery</title>
        <description>Pneumocephalus volume in patients who underwent posterior fossa surgery</description>
        <time_frame>one to six hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Conventional 1:1 Oxygen / Air Gas Mixture Ventilation</title>
            <description>Out of the 39 patients in the Conventional 1:1 oxygen / air gas mixture ventilation group, 15 patients underwent conventional posterior fossa surgery. Pneumocephalus volume was compared between groups for this patient sub-setting</description>
          </group>
          <group group_id="O2">
            <title>Pure Oxygen Ventilation After Hemostasis</title>
            <description>Out of the 31 patients in the pure oxygen ventilation after hemostasis group,11 patients underwent conventional posterior fossa surgery. Pneumocephalus volume was compared between groups for this patient sub-setting</description>
          </group>
        </group_list>
        <measure>
          <title>Pneumocephalus Volume and Posterior Fossa Surgery</title>
          <description>Pneumocephalus volume in patients who underwent posterior fossa surgery</description>
          <units>cm^3</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.38" lower_limit="0.81" upper_limit="10.50"/>
                    <measurement group_id="O2" value="4.00" lower_limit="0.60" upper_limit="13.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Neurological Outcomes at POD 3 Compared to Preoperative Evaluation</title>
        <description>Changes in Neurological Outcomes from baseline (preoperative evaluation) were documented based on differences (if any) found between both physical examinations: baseline (before surgery) and postoperative day (POD) 3 neurological exam. Results were reported as &quot;improvement&quot; (partial or total recovery of baseline neurological signs/symptoms), &quot;no changes&quot;, and &quot;deterioration&quot; (focal or global neurological deterioration) in comparison with baseline neurological examination</description>
        <time_frame>preoperative to postoperative day 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Conventional 1:1 Oxygen/Air Gas Mixture</title>
            <description>39 patients received ventilation during the surgery with a 1:1 oxygen / air gas mixture</description>
          </group>
          <group group_id="O2">
            <title>Pure Oxygen Ventilation</title>
            <description>31 patients received controlled ventilation with a conventional 1:1 oxygen / air gas mixture during the approach and tumor removal phases. Once tumor resection was completed and hemostasis started, this group of patients was switched to ventilation with pure oxygen (FiO2 = 100%) until extubation</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Neurological Outcomes at POD 3 Compared to Preoperative Evaluation</title>
          <description>Changes in Neurological Outcomes from baseline (preoperative evaluation) were documented based on differences (if any) found between both physical examinations: baseline (before surgery) and postoperative day (POD) 3 neurological exam. Results were reported as &quot;improvement&quot; (partial or total recovery of baseline neurological signs/symptoms), &quot;no changes&quot;, and &quot;deterioration&quot; (focal or global neurological deterioration) in comparison with baseline neurological examination</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Improvement from baseline</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No changes from baseline</title>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Deterioration from baseline</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected from the surgery start date / time to postoperative day 3</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Conventional 1:1 Oxygen/Air Gas Mixture</title>
          <description>39 patients received ventilation during the surgery with a 1:1 oxygen / air gas mixture</description>
        </group>
        <group group_id="E2">
          <title>Pure Oxygen Ventilation</title>
          <description>31 patients received controlled ventilation with a conventional 1:1 oxygen / air gas mixture (60% oxygen concentration) during the approach and tumor removal phases. Once tumor resection was completed and hemostasis started, this group of patients was switched to ventilation with pure oxygen (100% oxygen concentration) until extubation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Sample size calculations were based on published data and resulted in the trial being under-powered. We did not incorporate a second postoperative CT scan to evaluate the changes in pneumocephalus volume during the immediate postoperative period</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Juan Fiorda-Diaz Postdoctoral Researcher</name_or_title>
      <organization>The Ohio State University Wexner Medical Center</organization>
      <phone>6142933559</phone>
      <email>juan.fiorda@osumc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

